Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase

Carcinogenesis

Volumn 35, Issue 2, 2014, Pages 365-372

  Forester, Sarah C ^a   Lambert, Joshua D ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLIN D1; ENTACAPONE; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NORADRENALIN; REACTIVE OXYGEN METABOLITE; TOLCAPONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL FREE SYSTEM; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG POTENTIATION; FIBROBLAST; FLOW CYTOMETRY; G0 PHASE CELL CYCLE CHECKPOINT; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IC 50; LUNG CANCER; MALE; METHYLATION; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BENZOPHENONES; BLOTTING, WESTERN; CATECHIN; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; CELL CYCLE; CELL PROLIFERATION; CELL-FREE SYSTEM; DNA METHYLATION; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; LUNG NEOPLASMS; MALE; MICE; NITRILES; NITRO COMPOUNDS; NITROPHENOLS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 84893390660     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt347     Document Type: Article

References (38)

1. American Cancer Society (2013) Cancer Facts&Figures 2013. American Cancer Society, Atlanta, GA, pp. 64.
2. Yang,C.S. et al. (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer, 9, 429-439.
3. Landau,J.M. et al. (1998) Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis, 19, 501-507.
4. Liao,J. et al. (2004) Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr. Cancer, 48, 44-53.
5. Cao,J. et al. (1996) Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam. Appl. Toxicol., 29, 244-250.
6. Castro,D.J. et al. (2008) Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine. Carcinogenesis, 29, 1581-1586.
7. Schuller,H.M. et al. (2004) Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Lung Cancer, 45, 11-18.
8. Wang,Z.Y. et al. (1992) Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res., 52, 1943-1947.
9. Katiyar,S.K. et al. (1993) Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis, 14, 849-855.
10. Katiyar,S.K. et al. (1993) Protective effects of green tea polyphenols administered by oral intubation against chemical carcinogen-induced forestomach and pulmonary neoplasia in A/J mice. Cancer Lett., 73, 167-172.
11. Anderson,M.W. et al. (2008) Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice. Carcinogenesis, 29, 1594-1600.
12. Lu,G. et al. (2006) Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res., 66, 11494-11501.
13. Gu,Q. et al. (2009) Development of a rat model by 3,4-benzopyrene intrapulmonary injection and evaluation of the effect of green tea drinking on p53 and bcl-2 expression in lung carcinoma. Cancer Detect. Prev., 32, 444-451.
14. Kweon,M.H. et al. (2006) Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J. Biol. Chem., 281, 33761-33772.
15. Yang,G.Y. et al. (1998) Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis, 19, 611-616.
16. Li,G.X. et al. (2010) Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis, 31, 902-910.
17. Lambert,J.D. et al. (2003) Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr., 133, 4172-4177.
18. Lu,H. et al. (2003) Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab. Dispos., 31, 572-579.
19. Fang,M.Z. et al. (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res., 63, 7563-7570.
20. Landis-Piwowar,K. et al. (2010) Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG. Oncol. Rep., 24, 563-569.
21. Wu,A.H. et al. (2003) Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res., 63, 7526-7529.
22. Inoue-Choi,M. et al. (2010) Genetic association between the COMT genotype and urinary levels of tea polyphenols and their metabolites among daily green tea drinkers. Int. J. Mol. Epidemiol. Genet., 1, 114-123.
23. Miller,R.J. et al. (2012) The impact of the catechol-O-methyltransferase genotype on vascular function and blood pressure after acute green tea ingestion. Mol. Nutr. Food Res., 56, 966-975.
24. Brown,A.L. et al. (2011) Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br. J. Nutr., 106, 1880-1889.
25. Lees,A.J. (2008) Evidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinson's disease. CNS Neurosci. Ther., 14, 83-93.
26. De Santi,C. et al. (1998) Catechol-O-methyltransferase: variation in enzyme activity and inhibition by entacapone and tolcapone. Eur. J. Clin. Pharmacol., 54, 215-219.
27. Pan,L. et al. (2010) Simultaneous determination of levodopa, benserazide and 3-O-methyldopa in human serum by LC-MS-MS. Chromatographia, 72, 627-633.
28. Sang,S. et al. (2005) Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J. Agric. Food Chem., 53, 9478-9484.
29. Mackenzie,G.G. et al. (2004) Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J., 18, 167-169.
30. Yang,L.C. et al. (2011) Determination of neurotransmitter levels in models of Parkinson's disease by HPLC-ECD. In Manfredi,G. et al. (eds) Neurodegeneration: Methods Protocols. Vol. 793. Humana Press Inc., Totowa, NJ, pp. 401-415.
31. Tallarida,R.J. (2006) An overview of drug combination analysis with isobolograms. J. Pharmacol. Exp. Ther., 319, 1-7.
32. Korlipara,L.V. et al. (2004) Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells. Neuropharmacology, 46, 562-569.
33. Fischer,J.J. et al. (2010) Capture compound mass spectrometry sheds light on the molecular mechanisms of liver toxicity of two Parkinson drugs. Toxicol. Sci., 113, 243-253.
34. Haasio,K. et al. (2002) Effects of entacapone and tolcapone on mitochondrial membrane potential. Eur. J. Pharmacol., 453, 21-26.
35. Hseu,Y.C. et al. (2012) The chalcone flavokawain B induces G2/M cellcycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway. J. Agric. Food Chem., 60, 2385-2397.
36. Manohar,S.M. et al. (2012) Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1a and induces G2/M arrest under hypoxia in prostate cancer cells. Prostate Cancer Prostatic Dis., 15,15-27.
37. Roy,P. et al. (2010) Tea polyphenols inhibit cyclooxygenase-2 expression and block activation of nuclear factor-kappa B and Akt in diethylnitrosoamine induced lung tumors in Swiss mice. Invest. New Drugs, 28, 466-471.
38. Okabe,S. et al. (2001) Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol. Pharm. Bull., 24, 883-886.